Skip to contents

A simple dataset for demonstrating basic swimmer plot functionality. Contains patient timelines with treatment responses and basic categorization.

Usage

data(swimmer_unified_basic)

Format

A data frame with 10 rows and 6 variables:

PatientID

Character. Unique patient identifiers (PT001-PT010)

StartTime

Numeric. Treatment start time (all patients start at 0)

EndTime

Numeric. Treatment end time in months (5-15 months)

Response

Character. Best response (CR, PR, SD, PD)

Treatment

Character. Treatment type (Immunotherapy, Chemotherapy, Combination, Targeted)

Priority

Character. Patient priority level (High, Medium, Low)

Source

Generated for ClinicoPath package demonstration

Examples

data(swimmer_unified_basic)

# Basic swimmer plot
swimmerplot(
  data = swimmer_unified_basic,
  patientID = "PatientID",
  startTime = "StartTime", 
  endTime = "EndTime",
  responseVar = "Response"
)
#> 
#>  SWIMMER PLOT
#> 
#>  <div style='color: #8a6d00; background-color: #fff8e1; padding: 15px;
#>  border: 1px solid #ffc107; border-radius: 5px; margin: 10px;'>
#> 
#>  Analysis Information
#> 
#>  Some response categories have <3 patients. Consider grouping
#>  categories for meaningful analysis.
#> 
#>  Timeline Summary Statistics         
#>  ─────────────────────────────────── 
#>    Metric                Value       
#>  ─────────────────────────────────── 
#>    Number of Patients    10.000000   
#>    Total Observations    10.000000   
#>    Median Duration        9.500000   
#>    Mean Duration          9.700000   
#>    Total Person-Time     97.000000   
#>    Mean Follow-up         9.700000   
#>    CR Rate (%)           30.000000   
#>    PD Rate (%)           20.000000   
#>    PR Rate (%)           30.000000   
#>    SD Rate (%)           20.000000   
#>  ─────────────────────────────────── 
#> 
#> 
#>  <div style='background-color: #e8f5e8; padding: 15px; border-radius:
#>  5px; margin: 10px 0;'>
#> 
#>  Clinical Interpretation
#> 
#>  <div style='margin: 10px 0;'><h5 style='color: #2e7d32;'>Timeline
#>  Analysis:
#> 
#>  Study included 10 patients with 10 timeline observations. Median
#>  follow-up was 9.5 months (range: 5.0 to 15.0 months).
#> 
#>  <div style='margin: 10px 0;'><h5 style='color: #2e7d32;'>Person-Time
#>  Analysis:
#> 
#>  Total person-time: 97.0 months. Average follow-up per patient: 9.7
#>  months.
#> 
#>  <div style='margin: 10px 0;'><h5 style='color: #2e7d32;'>Response
#>  Pattern Analysis:
#> 
#>  Most common response was CR (30.0% of observations). Response
#>  distribution shows clinical patterns suitable for efficacy analysis.
#> 
#>  Person-Time Analysis                                                          
#>  ───────────────────────────────────────────────────────────────────────────── 
#>    Response Type    Patients    Total Time    Mean Time    Follow-up Density   
#>  ───────────────────────────────────────────────────────────────────────────── 
#>    CR                      3      35.00000    11.670000             8.571000   
#>    PD                      2      16.00000     8.000000            12.500000   
#>    PR                      3      24.00000     8.000000            12.500000   
#>    SD                      2      22.00000    11.000000             9.091000   
#>  ───────────────────────────────────────────────────────────────────────────── 
#> 
#> 
#>  Milestone Event Summary                              
#>  ──────────────────────────────────────────────────── 
#>    Milestone    Events    Median Time    Time Range   
#>  ──────────────────────────────────────────────────── 
#>  ──────────────────────────────────────────────────── 
#> 
#> 
#>  Advanced Clinical Metrics                                                                                                                                       
#>  ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── 
#>    Metric                           Value        95% CI         Unit                 Clinical Interpretation                                                     
#>  ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── 
#>    Median Follow-up Time             9.500000                   months               Central tendency of patient follow-up duration                              
#>    Interquartile Range               4.500000                   months               Middle 50% of follow-up duration range                                      
#>    Total Study Person-Time          97.000000                   months cumulative    Total observation time across all patients                                  
#>    Follow-up Density                10.309000                   per 100 months       Number of patients per 100 units of observation time (descriptive metric)   
#>    Objective Response Rate (ORR)    60.000000    26.2 - 87.8    percent              Proportion with complete or partial response                                
#>    Disease Control Rate (DCR)       80.000000    44.4 - 97.5    percent              Proportion with response or stable disease                                  
#>  ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── 
#>